A randomized double blind controlled trial of the efficacy and safety of Polycap (Quintapill) versus its components in subjects with at least one additional cardiovascular risk factor
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Hydrochlorothiazide/atenolol/ramipril/simvastatin/aspirin (Primary) ; Aspirin; Atenolol; Hydrochlorothiazide; Ramipril; Simvastatin
- Indications Cardiovascular disorders
- Focus Therapeutic Use
- Acronyms TIPS
- Sponsors Cadila Pharmaceuticals
- 22 Sep 2010 Actual end date (1 Oct 2008) added as reported by ClinicalTrials.gov.
- 03 Feb 2010 New source identified and integrated (Clinical Trials Registry - India, CTRI2007-091-000015).
- 16 Jun 2009 Hydrochlorothiazide/atenolol/ramipril/simvastatin/aspirin added as a drug treatment